Who Paid My Doc
ReActiv8
Device Pain Management
General payments
$4,501,122
Research payments
$6,741,735
Through program year 2025, $4,501,122 in general payments and $6,741,735 in research payments were reported against ReActiv8 (Pain Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $814,667 | 4,030 |
| 2025 | Research | $971,973 | 159 |
| 2024 | General | $954,738 | 2,581 |
| 2024 | Research | $1,172,078 | 225 |
| 2023 | General | $853,438 | 3,297 |
| 2023 | Research | $2,371,736 | 311 |
| 2022 | General | $1,404,171 | 3,143 |
| 2022 | Research | $1,723,582 | 238 |
| 2021 | General | $474,109 | 1,048 |
| 2021 | Research | $502,365 | 65 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
14,099 general · 998 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.